ULTRASOUND MEASUREMENT OF PERIPHERAL ENDOTHELIAL DYSFUNCTION IN TYPE 2 DIABETIC PATIENTS: CORRELATION WITH RISK FACTORS

被引:3
作者
Bosevski, Marijan [1 ]
Georgievska-Ismail, Ljubica [1 ]
机构
[1] Univ Clin Cardiol, Fac Med, Skopje 1000, North Macedonia
关键词
endothelial dysfunction; ultrasound; type; 2; diabetes; BRACHIAL-ARTERY; CORONARY; DILATATION;
D O I
10.17305/bjbms.2010.2699
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
100103 [病原生物学]; 100218 [急诊医学];
摘要
The purpose of the study was to assess the endothelial dysfunction (ED) in type 2 diabetic patients ultrasonographicaly and estimate the correlation of ED with glycemia and other cardio-metabolic risk factors. 171 patient (age 60,0 + 8,5 years) with diagnosed type 2 diabetes and coronary artery disease (CAD) were randomly included in a cross sectional study. B-mode ultrasound system with a linear transducer of 7.5 MHz was used for evaluation of flow-mediated vasodilation in brachial artery (FMV). FMV was presented as a change of brachial artery diameter at rest and after limb ischemia, previously provoked by cuff inflation. Peripheral ED was found in 77,2% (132 patients). Multivariate logistic regression model defined: age (OR 1,071, 95% CI 1,003 1,143) and plasma cholesterol (OR 4,083 95%CI 1,080 17,017) as determinants for ED. Linear multivariate analysis presented duration of diabetes (Beta 0,173, Sig 0,024), and glycemia (Beta 0,132, Sig 0,044) to be associated independently with FMV value. Estimated factors influencing FMV, might be potential therapeutic targets for presented endothelial dysfunction in type 2 diabetic patients with coronary artery disease.
引用
收藏
页码:84 / 88
页数:5
相关论文
共 22 条
[1]
Effects of improved glycaemic control on endothelial function in patients with type 2 diabetes [J].
Bagg, W ;
Whalley, GA ;
Gamble, G ;
Drury, PL ;
Sharpe, N ;
Braatvedt, GD .
INTERNAL MEDICINE JOURNAL, 2001, 31 (06) :322-328
[2]
Beckman Joshua A., 2004, Diabetes and Cardiovascular Disease
[3]
The effect of statin therapy on endothelial function in type 2 diabetes without manifest cardiovascular disease [J].
Beishuizen, ED ;
Tamsma, JT ;
Jukema, J ;
Van de Ree, MA ;
VAn der Vijver, JCM ;
Meinders, AE ;
Huisman, MV .
DIABETES CARE, 2005, 28 (07) :1668-1674
[4]
Flow associated or flow mediated dilatation? More than just semantics [J].
Bhagat, K ;
Hingorani, A ;
Vallance, P .
HEART, 1997, 78 (01) :7-8
[5]
Bosevski M, 2009, Prilozi, V30, P81
[6]
Is assessment of peripheral endothelial dysfunction useful tool for risk stratification of type 2 diabetic patients with manifested coronary artery disease? [J].
Bosevski, M. ;
Borozanov, V. ;
Tosev, S. ;
Georgievska-Ismail, Lj. .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2009, 131 (02) :290-292
[7]
ENDOTHELIUM-DEPENDENT DILATION IN THE SYSTEMIC ARTERIES OF ASYMPTOMATIC SUBJECTS RELATES TO CORONARY RISK-FACTORS AND THEIR INTERACTION [J].
CELERMAJER, DS ;
SORENSEN, KE ;
BULL, C ;
ROBINSON, J ;
DEANFIELD, JE .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1994, 24 (06) :1468-1474
[8]
Effect of atorvastatin and irbesartan, alone and in combination, on postprandial endothelial dysfunction, oxidative stress, and inflammation in type 2 diabetic patients [J].
Ceriello, A ;
Assaloni, R ;
Da Ros, R ;
Maier, A ;
Piconi, L ;
Quagliaro, L ;
Esposito, K ;
Giugliano, D .
CIRCULATION, 2005, 111 (19) :2518-2524
[9]
Endothelial dysfunction in diabetes [J].
De Vriese, AS ;
Verbeuren, TJ ;
Van de Voorde, J ;
Lameire, NH ;
Vanhoutte, PM .
BRITISH JOURNAL OF PHARMACOLOGY, 2000, 130 (05) :963-974
[10]
Preserved endothelial function in IDDM patients, but not in NIDDM patients, compared with healthy subjects [J].
Enderle, MD ;
Benda, N ;
Schmuelling, RM ;
Haering, HU ;
Pfohl, M .
DIABETES CARE, 1998, 21 (02) :271-277